Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease

被引:1
|
作者
Roberts, Chris-Tiann [1 ]
Raabe, Nicole [1 ]
Wiegand, Lara [1 ]
Shahib, Ashraf Kadar [1 ]
Rastegar, Mojgan [1 ]
机构
[1] Univ Manitoba, Rady Fac Hlth Sci, Dept Biochem & Med Genet, Max Rady Coll Med, Winnipeg, MB R3E 0J9, Canada
基金
加拿大健康研究院;
关键词
metformin; drug repurposing; epigenetics; human disease; type; 2; diabetes; ORGANIC CATION TRANSPORTERS; EPIGENETIC MECHANISMS; SPATIAL MEMORY; BRAIN-BARRIER; GLUCOSE; EXPRESSION; COMPLEX; AUTOPHAGY; PROTECTS; MODEL;
D O I
10.3390/ph17121601
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metformin is a commonly used drug for treating type 2 diabetes. Metformin is an inexpensive drug with low/no side effects and is well tolerated in human patients of different ages. Recent therapeutic strategies for human disease have considered the benefits of drug repurposing. This includes the use of the anti-diabetic drug metformin. Accordingly, the anti-inflammatory, anti-cancer, anti-viral, neuroprotective, and cardioprotective potentials of metformin have deemed it a suitable candidate for treating a plethora of human diseases. As results from preclinical studies using cellular and animal model systems appear promising, clinical trials with metformin in the context of non-diabetes-related illnesses have been started. Here, we aim to provide a comprehensive overview of the therapeutic potential of metformin in different animal models of human disease and its suggested relationship to epigenetics and ailments with epigenetic components.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Treatment with the anti-diabetic drug metformin ameliorates betel-nut induced carcinogenesis in a murine model
    Jeny Laskar
    Mahuya Sengupta
    Yashmin Choudhury
    Pharmacological Reports, 2019, 71 : 1115 - 1124
  • [32] THE ANTI-DIABETIC DRUG METFORMIN SENSITIZES HUMAN NON-SMALL CELL LUNG CANCER (NSCLC) XENOGRAFTS TO IONIZING RADIATION.
    Tsakiridis, Theodoros
    Storozhuk, Yaryna
    Sanli, Toran
    Hopmans, Sarah
    Cutz, J. C.
    Tsiani, Evangelia
    Wright, Jim
    Singh, Gurmit
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S571 - S572
  • [33] Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
    Plowman, Trevor J.
    Christensen, Hannah
    Aiges, Myia
    Fernandez, Emely
    Shah, Mujtaba H.
    Ramana, Kota V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [34] Synthesis and Characterization of New Derivatives of Metformin with Expected Anti-diabetic Effects
    Hamed, Ahmed Solaiman
    Ali, Ehab M.
    Gayed, Asma Adil
    EGYPTIAN JOURNAL OF CHEMISTRY, 2020, 64 (06): : 2973 - 2982
  • [35] Reliable prediction of anti-diabetic drug failure using a reject option
    Kang, Seokho
    Cho, Sungzoon
    Rhee, Su-jin
    Yu, Kyung-Sang
    PATTERN ANALYSIS AND APPLICATIONS, 2017, 20 (03) : 883 - 891
  • [36] New insights into the anti-diabetic actions of metformin: from the liver to the gut
    Wu, Tongzhi
    Horowitz, Michael
    Rayner, Christopher K.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (02) : 157 - 166
  • [37] Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats
    Pandey, Shruti
    Garabadu, Debapriya
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2017, 37 (05) : 791 - 802
  • [38] Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone
    Nankar, Rakesh P.
    Doble, Mukesh
    PHYTOMEDICINE, 2017, 37 : 4 - 9
  • [39] Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
    Greco, Alessia
    Coperchini, Francesca
    Croce, Laura
    Magri, Flavia
    Teliti, Marsida
    Rotondi, Mario
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries
    Neubert, Antje
    Hsia, Yingfen
    de Jong-van den Berg, Lolkje T. W.
    Janhsen, Katrin
    Glaeske, Gerd
    Furu, Kari
    Kieler, Helle
    Norgaard, Mette
    Clavenna, Antonio
    Wong, Ian C. K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (06) : 969 - 977